Citation Impact
Citing Papers
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
2010 StandoutScience
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
2012 StandoutScienceNobel
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells
2016
Localized cell stimulation by nitric oxide using a photoactive porous coordination polymer platform
2013 StandoutNobel
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Reconstituted Immunity against Persistent Parvovirus B19 Infection in a Patient with Acquired Immunodeficiency Syndrome after Highly Active Antiretroviral Therapy
2001
Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
2005
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
1994
Imaging of cAMP Levels and Protein Kinase A Activity Reveals That Retinal Waves Drive Oscillations in Second-Messenger Cascades
2006 StandoutNobel
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1998 StandoutNature
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
1996 Nature
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Molecular architecture of native HIV-1 gp120 trimers
2008 Nature
Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers
2012
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
NS1 Protein of Parvovirus B19 Interacts Directly with DNA Sequences of the p6 Promoter and with the Cellular Transcription Factors Sp1/Sp3
2002
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Quantitative Analysis of Neutralizing Immune Responses to Human Parvovirus B19 Using a Novel Reverse Transcriptase–Polymerase Chain Reaction–Based Assay
1999
Progress on new vaccine strategies against chronic viral infections
2004
Challenges for structure-based HIV vaccine design
2009
Calmodulin Controls Synaptic Strength via Presynaptic Activation of Calmodulin Kinase II
2010 StandoutNobel
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Antibodies to parvovirus B19 non‐structural protein are associated with chronic but not acute arthritis following B19 infection
2000
Mechanism of anion permeation through channels gated by glycine and gamma‐aminobutyric acid in mouse cultured spinal neurones.
1987 StandoutNobel
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
Parvovirus B19
2004 Standout
Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells.
1982 StandoutNobel
Phospholipase A2 Activity-Dependent Stimulation of Ca 2+ Entry by Human Parvovirus B19 Capsid Protein VP1
2006
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
1996
Crystal Structures of Protein-Bound Cyclic Peptides
2019
HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte
1998 Standout
Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses
2007
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
2004
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
1997
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
1991 Standout
Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
2015
Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization
1997
A Bispecific Antibody Composed of a Nonneutralizing Antibody to the gp41 Immunodominant Region and an Anti-CD89 Antibody Directs Broad Human Immunodeficiency Virus Destruction by Neutrophils
2008
Human Parvovirus B19
2002 Standout
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization
2016
Unmutated Immunoglobulin M Can Protect Mice from Death by Influenza Virus Infection
2003 StandoutNobel
Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons.
1988 StandoutNobel
Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites
2015
Bcl-2-mediated alterations in endoplasmic reticulum Ca 2+ analyzed with an improved genetically encoded fluorescent sensor
2004 StandoutNobel
Activation of a potassium current by rapid photochemically generated step increases of intracellular calcium in rat sympathetic neurons.
1987 StandoutNobel
Channelrhodopsin-2, a directly light-gated cation-selective membrane channel
2003 Standout
Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity
1998
Intracellular calcium dependence of large dense-core vesicle exocytosis in the absence of synaptotagmin I
2001 StandoutNobel
Membrane Fusion and Exocytosis
1999 StandoutNobel
Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding
1995
Ion channels in synaptic vesicles from Torpedo electric organ.
1988 StandoutNobel
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
1993
Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism
2007
Antigenic Variation within the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120: Effects on Chemokine Receptor Utilization
2001
Truncation of the Cytoplasmic Domain Induces Exposure of Conserved Regions in the Ectodomain of Human Immunodeficiency Virus Type 1 Envelope Protein
2002
Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses.
1991 StandoutNobel
Fast calcium transients in rat peritoneal mast cells are not sufficient to trigger exocytosis.
1986 StandoutNobel
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.
1995
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
The growth cones of Aplysia sensory neurons: Modulation by serotonin of action potential duration and single potassium channel currents
1986 StandoutNobel
GP120: Biologic Aspects of Structural Features
2001
Progress on new vaccine strategies against chronic viral infections
2004
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Voltage dependence of K + channels in guard-cell protoplasts
1987 StandoutNobel
The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability
2001
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development
1997
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Scanning the human proteome for calmodulin-binding proteins
2005 StandoutNobel
The VP1 Unique Region of Parvovirus B19 and Its Constituent Phospholipase A2-Like Activity
2002
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
1995
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
The Cerebellum-Specific Munc13 Isoform Munc13-3 Regulates Cerebellar Synaptic Transmission and Motor Learning in Mice
2001 StandoutNobel
HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing Epitopes
2012
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120
1995
Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction
2016 StandoutNobel
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
1993
Works of Constance Williams being referenced
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1
2008
Generation of Neutralizing Anti-B19 Parvovirus Human Monoclonal Antibodies from Patients Infected with Human Immunodeficiency Virus
1993
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
2010
Production of Human Monoclonal Antibodies Specific for Conformational and Linear Non-V3 Epitopes of gp120
1992
Thermodynamic Signatures of the Antigen Binding Site of mAb 447–52D Targeting the Third Variable Region of HIV-1 gp120
2013
Conserved structural elements in the V3 crown of HIV-1 gp120
2010
Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D
2004
Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles
2005
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.
1991
Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1
2006
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
2014
The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope
2004
Mapping of Epitopes Exposed on Intact Human Immunodeficiency Virus Type 1 (HIV-1) Virions: a New Strategy for Studying the Immunologic Relatedness of HIV-1
1998
Conserved and Exposed Epitopes on Intact, Native, Primary Human Immunodeficiency Virus Type 1 Virions of Group M
2000
Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades
2002
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
1999
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.
1997
Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D
1994
Immunoreactivity of Intact Virions of Human Immunodeficiency Virus Type 1 (HIV-1) Reveals the Existence of Fewer HIV-1 Immunotypes than Genotypes
2000
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1
1994